These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 23570576)

  • 1. Mast cells: a pivotal role in pulmonary fibrosis.
    Veerappan A; O'Connor NJ; Brazin J; Reid AC; Jung A; McGee D; Summers B; Branch-Elliman D; Stiles B; Worgall S; Kaner RJ; Silver RB
    DNA Cell Biol; 2013 Apr; 32(4):206-18. PubMed ID: 23570576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latent transforming growth factor-beta-binding protein-4 regulates transforming growth factor-beta1 bioavailability for activation by fibrogenic lung fibroblasts in response to bleomycin.
    Zhou Y; Koli K; Hagood JS; Miao M; Mavalli M; Rifkin DB; Murphy-Ullrich JE
    Am J Pathol; 2009 Jan; 174(1):21-33. PubMed ID: 19056849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bleomycin-induced pulmonary fibrosis in genetically mast cell-deficient WBB6F1-W/Wv mice and mechanism of the suppressive effect of tranilast, an antiallergic drug inhibiting mediator release from mast cells, on fibrosis.
    Mori H; Kawada K; Zhang P; Uesugi Y; Sakamoto O; Koda A
    Int Arch Allergy Appl Immunol; 1991; 95(2-3):195-201. PubMed ID: 1718909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of high-mobility group box 1 and thrombin in murine pulmonary fibrosis and the therapeutic potential of thrombomodulin.
    Kida T; Seno T; Nagahara H; Inoue T; Nakabayashi A; Kukida Y; Fujioka K; Fujii W; Wada M; Kohno M; Kawahito Y
    Am J Physiol Lung Cell Mol Physiol; 2018 Mar; 314(3):L473-L483. PubMed ID: 29212801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Animal model of sclerotic skin. II. Bleomycin induced scleroderma in genetically mast cell deficient WBB6F1-W/W(V) mice.
    Yamamoto T; Takahashi Y; Takagawa S; Katayama I; Nishioka K
    J Rheumatol; 1999 Dec; 26(12):2628-34. PubMed ID: 10606374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thalidomide prevents bleomycin-induced pulmonary fibrosis in mice.
    Tabata C; Tabata R; Kadokawa Y; Hisamori S; Takahashi M; Mishima M; Nakano T; Kubo H
    J Immunol; 2007 Jul; 179(1):708-14. PubMed ID: 17579094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Necrostatin-1 Alleviates Bleomycin-Induced Pulmonary Fibrosis and Extracellular Matrix Expression in Interstitial Pulmonary Fibrosis.
    Mou F; Mou C
    Med Sci Monit; 2020 Feb; 26():e919739. PubMed ID: 32019905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D suppresses bleomycin-induced pulmonary fibrosis by targeting the local renin-angiotensin system in the lung.
    Chang J; Nie H; Ge X; Du J; Liu W; Li X; Sun Y; Wei X; Xun Z; Li YC
    Sci Rep; 2021 Aug; 11(1):16525. PubMed ID: 34400742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The calpain inhibitor calpeptin prevents bleomycin-induced pulmonary fibrosis in mice.
    Tabata C; Tabata R; Nakano T
    Clin Exp Immunol; 2010 Dec; 162(3):560-7. PubMed ID: 20846163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osthole Alleviates Bleomycin-Induced Pulmonary Fibrosis via Modulating Angiotensin-Converting Enzyme 2/Angiotensin-(1-7) Axis and Decreasing Inflammation Responses in Rats.
    Hao Y; Liu Y
    Biol Pharm Bull; 2016; 39(4):457-65. PubMed ID: 26822530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective role of gambogic acid in experimental pulmonary fibrosis in vitro and in vivo.
    Qu Y; Zhang G; Ji Y; Zhua H; Lv C; Jiang W
    Phytomedicine; 2016 Apr; 23(4):350-8. PubMed ID: 27002405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic alcohol ingestion primes the lung for bleomycin-induced fibrosis in mice.
    Sueblinvong V; Kerchberger VE; Saghafi R; Mills ST; Fan X; Guidot DM
    Alcohol Clin Exp Res; 2014 Feb; 38(2):336-43. PubMed ID: 24033682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of dual-specificity protein phosphatase DUSP10/MKP-5 in pulmonary fibrosis.
    Xylourgidis N; Min K; Ahangari F; Yu G; Herazo-Maya JD; Karampitsakos T; Aidinis V; Binzenhöfer L; Bouros D; Bennett AM; Kaminski N; Tzouvelekis A
    Am J Physiol Lung Cell Mol Physiol; 2019 Nov; 317(5):L678-L689. PubMed ID: 31483681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of bleomycin induced lung fibrosis by candesartan cilexetil, an angiotensin II type 1 receptor antagonist.
    Otsuka M; Takahashi H; Shiratori M; Chiba H; Abe S
    Thorax; 2004 Jan; 59(1):31-8. PubMed ID: 14694243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanical stress-induced mast cell degranulation activates TGF-β1 signalling pathway in pulmonary fibrosis.
    Shimbori C; Upagupta C; Bellaye PS; Ayaub EA; Sato S; Yanagihara T; Zhou Q; Ognjanovic A; Ask K; Gauldie J; Forsythe P; Kolb MRJ
    Thorax; 2019 May; 74(5):455-465. PubMed ID: 30808717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overcoming interferon (IFN)-γ resistance ameliorates transforming growth factor (TGF)-β-mediated lung fibroblast-to-myofibroblast transition and bleomycin-induced pulmonary fibrosis.
    Chang CJ; Lin CF; Lee CH; Chuang HC; Shih FC; Wan SW; Tai C; Chen CL
    Biochem Pharmacol; 2021 Jan; 183():114356. PubMed ID: 33285108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of lncRNA PFRL prevents pulmonary fibrosis by disrupting the miR-26a/smad2 loop.
    Jiang H; Chen Y; Yu T; Zhao X; Shan H; Sun J; Zhang L; Li X; Shan H; Liang H
    Am J Physiol Lung Cell Mol Physiol; 2018 Oct; 315(4):L563-L575. PubMed ID: 29952219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The KCa3.1 blocker TRAM-34 inhibits proliferation of fibroblasts in paraquat-induced pulmonary fibrosis.
    Xie H; Lu J; Zhu Y; Meng X; Wang R
    Toxicol Lett; 2018 Oct; 295():408-415. PubMed ID: 30036685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of mast cell chymase in bleomycin-induced pulmonary fibrosis in mice.
    Tomimori Y; Muto T; Saito K; Tanaka T; Maruoka H; Sumida M; Fukami H; Fukuda Y
    Eur J Pharmacol; 2003 Oct; 478(2-3):179-85. PubMed ID: 14575803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorofenidone attenuates bleomycin-induced pulmonary fibrosis by inhibiting eukaryotic translation initiation factor 3a (eIF3a) in rats.
    Wu YH; Li XW; Li WQ; Li XH; Li YJ; Hu GY; Liu ZQ; Li D
    Eur J Pharmacol; 2016 Feb; 773():42-50. PubMed ID: 26821114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.